Pacific Biosciences Of Stock Market Value
| PACB Stock | USD 1.71 0.00 0.00% |
| Symbol | Pacific |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. Anticipated expansion of Pacific directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pacific Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.82) | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets | Return On Equity |
Understanding Pacific Biosciences requires distinguishing between market price and book value, where the latter reflects Pacific's accounting equity. The concept of intrinsic value - what Pacific Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Pacific Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Pacific Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pacific Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pacific Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Pacific Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pacific Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pacific Biosciences.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Pacific Biosciences on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Pacific Biosciences of or generate 0.0% return on investment in Pacific Biosciences over 90 days. Pacific Biosciences is related to or competes with Avanos Medical, Orthofix Medical, Si Bone, Butterfly Network, DarioHealth Corp, Iovance Biotherapeutics, and Integra LifeSciences. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically co... More
Pacific Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pacific Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pacific Biosciences of upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.08 | |||
| Information Ratio | 0.0081 | |||
| Maximum Drawdown | 29.88 | |||
| Value At Risk | (8.44) | |||
| Potential Upside | 10.33 |
Pacific Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pacific Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pacific Biosciences' standard deviation. In reality, there are many statistical measures that can use Pacific Biosciences historical prices to predict the future Pacific Biosciences' volatility.| Risk Adjusted Performance | 0.0249 | |||
| Jensen Alpha | 0.046 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.0091 | |||
| Treynor Ratio | 0.1058 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacific Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pacific Biosciences February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0249 | |||
| Market Risk Adjusted Performance | 0.1158 | |||
| Mean Deviation | 4.62 | |||
| Semi Deviation | 4.79 | |||
| Downside Deviation | 5.08 | |||
| Coefficient Of Variation | 4944.68 | |||
| Standard Deviation | 5.75 | |||
| Variance | 33.04 | |||
| Information Ratio | 0.0081 | |||
| Jensen Alpha | 0.046 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.0091 | |||
| Treynor Ratio | 0.1058 | |||
| Maximum Drawdown | 29.88 | |||
| Value At Risk | (8.44) | |||
| Potential Upside | 10.33 | |||
| Downside Variance | 25.82 | |||
| Semi Variance | 22.98 | |||
| Expected Short fall | (5.76) | |||
| Skewness | 0.5437 | |||
| Kurtosis | 0.3847 |
Pacific Biosciences Backtested Returns
Pacific Biosciences appears to be dangerous, given 3 months investment horizon. Pacific Biosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.0374, which implies the firm had a 0.0374 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Pacific Biosciences, which you can use to evaluate the volatility of the company. Please evaluate Pacific Biosciences' Coefficient Of Variation of 4944.68, risk adjusted performance of 0.0249, and Semi Deviation of 4.79 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pacific Biosciences holds a performance score of 2. The company holds a Beta of 1.0, which implies a somewhat significant risk relative to the market. Pacific Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Pacific Biosciences is expected to follow. Please check Pacific Biosciences' downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to make a quick decision on whether Pacific Biosciences' historical price patterns will revert.
Auto-correlation | 0.65 |
Good predictability
Pacific Biosciences of has good predictability. Overlapping area represents the amount of predictability between Pacific Biosciences time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pacific Biosciences price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Pacific Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:Check out Pacific Biosciences Correlation, Pacific Biosciences Volatility and Pacific Biosciences Performance module to complement your research on Pacific Biosciences. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Pacific Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.